Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: dbblg who wrote (95558)	3/5/2000 10:57:00 AM
From: Sam Sara	Read Replies (1) \| Respond to of 164684

Any thoughts on when and if YHOO will ever add a tiered service, where there is "premium" content. I use YHOO constantly- I would pay for the content at this point. If they can pull that off, market cap will probably double in 3 months or less.

To: dbblg who wrote (95558)	3/5/2000 12:40:00 PM
From: H James Morris	Read Replies (1) \| Respond to of 164684

>Meanwhile, a small-cap from the town I grew up in became my largest holding for the first--and probably last--time on Friday... Tell me more... It's not fair to keep Gems to yourself. Re: San Diego.. we're very much into Bio-techs here. Too many to name, but how about our Nanogen? It's only up 347% YTD! >SAN DIEGO, Feb. 18 /PRNewswire/ -- Nanogen, Inc. (Nasdaq: NGEN) announced today that it has filed a registration statement with the Securities and Exchange Commission for a public offering of 2,500,000 shares of its common stock (excluding 375,000 shares to cover over-allotments, if any). The 2,500,000 shares are being sold by the company. If the underwriters exercise their over-allotment option, up to an additional 145,355 shares may be sold by the company and up to 229,645 shares may be sold by selling stockholders. Warburg Dillon Read LLC, Lehman Brothers Inc., Pacific Growth Equities, Inc., Dain Rauscher Inc. and First Union Securities, Inc. are managing the offering. Nanogen integrates advanced microelectronics and molecular biology into a core technology platform with broad and diverse commercial applications in the fields of genomics, biomedical research, medical diagnostics, drug discovery forensics, agriculture, environmental testing and potentially the electronics and telecommunications industries. Nanogen has developed an integrated system, the NanoChip(TM) molecular biology workstation, comprised of two automated instruments and a consumable cartridge. The NanoChip(TM) cartridge, incorporating a proprietary microchip, provides a flexible tool for the rapid identification and precision analysis of biological test samples containing charged molecules.